Haematologica (May 2020)
IKZF1/3 and CRL4CRBN E3 ubiquitin ligase mutations and resistance to immunomodulatory drugs in multiple myeloma
- Santiago Barrio,
- Umair Munawar,
- Yuan Xiao Zhu,
- Nicola Giesen,
- Chang-Xin Shi,
- Matteo Da Viá,
- Ricardo Sanchez,
- Laura Bruins,
- Theresa Demler,
- Nicole Müller,
- Larissa Haertle,
- Andoni Garitano,
- Torsten Steinbrunn,
- Sophia Danhof,
- Isabel Cuenca,
- Clara Barrio-Garcia,
- Esteban Braggio,
- Andreas Rosenwald,
- Joaquin Martinez-Lopez,
- Leo Rasche,
- Marc S. Raab,
- A. Keith Stewart,
- Hermann Einsele,
- Thorsten Stühmer,
- K. Martin Kortüm
Affiliations
- Santiago Barrio
- Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany
- Umair Munawar
- Comprehensive Cancer Center Mainfranken, University Hospital of Würzburg, Würzburg, Germany
- Yuan Xiao Zhu
- Department of Hematology, Mayo Clinic, Scottsdale, AZ, USA
- Nicola Giesen
- Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany and CCU Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Germany
- Chang-Xin Shi
- Department of Hematology, Mayo Clinic, Scottsdale, AZ, USA
- Matteo Da Viá
- Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany
- Ricardo Sanchez
- Hematology Department Hospital 12 de Octubre, Complutense University, H12O-CNIO Clinical Research Unit, CIBERONC Madrid, Spain
- Laura Bruins
- Department of Hematology, Mayo Clinic, Scottsdale, AZ, USA
- Theresa Demler
- Comprehensive Cancer Center Mainfranken, University Hospital of Würzburg, Würzburg, Germany
- Nicole Müller
- Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany
- Larissa Haertle
- Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany
- Andoni Garitano
- Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany
- Torsten Steinbrunn
- Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany
- Sophia Danhof
- Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany
- Isabel Cuenca
- Hematology Department Hospital 12 de Octubre, Complutense University, H12O-CNIO Clinical Research Unit, CIBERONC Madrid, Spain
- Clara Barrio-Garcia
- Gene Center, Ludwig-Maximilians University, Munich, Germany
- Esteban Braggio
- Department of Hematology, Mayo Clinic, Scottsdale, AZ, USA
- Andreas Rosenwald
- Institute of Pathology, University of Würzburg, Würzburg, Germany
- Joaquin Martinez-Lopez
- Hematology Department Hospital 12 de Octubre, Complutense University, H12O-CNIO Clinical Research Unit, CIBERONC Madrid, Spain
- Leo Rasche
- Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany
- Marc S. Raab
- Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany and CCU Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Germany
- A. Keith Stewart
- Department of Hematology, Mayo Clinic, Scottsdale, AZ, USA;Center for Individualized Medicine of the Mayo Clinic, Rochester, MN, USA
- Hermann Einsele
- Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany
- Thorsten Stühmer
- Comprehensive Cancer Center Mainfranken, University Hospital of Würzburg, Würzburg, Germany
- K. Martin Kortüm
- Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany
- DOI
- https://doi.org/10.3324/haematol.2019.217943
- Journal volume & issue
-
Vol. 105,
no. 5
Abstract
No abstracts available.
